Fallopian tube disorder
MONDO:0002156A disease involving the fallopian tube.
Also known as: disease of fallopian tube, disease or disorder of fallopian tube, disorder of fallopian tube, fallopian tube disease, fallopian tube disease or disorder, fallopian tube disorder
428 clinical trials for this condition and its sub-types, 5 tagged with Fallopian tube disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Fallopian tube disorder
-
Fallopian tube neoplasm 199 trials · 417 incl. sub-types
5 sub-types
- Fallopian tube cancer 298 trials · 408 incl. sub-types Sub-types →
- Fallopian tube mucinous tumor 1 trial · 10 incl. sub-types Sub-types →
- Fallopian tube endometrioid tumor 3 trials
- Fallopian tube benign neoplasm 0 trials Sub-types →
- Fallopian tube germ cell tumor 0 trials Sub-types →
-
Salpingitis 2 trials · 10 incl. sub-types
6 sub-types
- Tuberculous salpingitis 0 trials · 7 incl. sub-types Sub-types →
- Salpingo-oophoritis 1 trial Sub-types →
- Acute salpingitis 0 trials Sub-types →
- Chronic salpingitis 0 trials Sub-types →
- Gonococcal salpingitis 0 trials Sub-types →
- Pyosalpinx 0 trials
-
Hydrosalpinx 1 trial
-
Tubal pregnancy 1 trial
-
Embryonic cyst of fallopian tube 0 trials
1 sub-type
- Parovarian cyst 0 trials
-
Fallopian tube endometriosis 0 trials
Most studied deeper sub-types
-
New drug cocktail aims to fight tough gynecological cancers
Disease control Recruiting nowThis study tests a drug called relacorilant, taken as a pill, combined with two standard chemotherapy drugs (nab-paclitaxel and bevacizumab) in people with ovarian, fallopian tube, peritoneal, or endometrial cancers. The goal is to see if the combination can slow cancer growth or…
Phase 2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New drug combo shows promise for Hard-to-Treat ovarian cancer
Disease control Recruiting nowThis phase 2 trial is testing a combination of the targeted drug mirvetuximab soravtansine and the chemotherapy carboplatin as a first treatment for women with advanced ovarian, fallopian tube, or primary peritoneal cancer that has a specific marker (folate receptor alpha). About…
Phase 2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Laser acupoints: a Needle-Free hope for blocked tubes?
Disease control Recruiting nowThis study tests if laser acupoint therapy can help unblock fallopian tubes in women trying to get pregnant. 36 women aged 20-35 with blocked tubes will receive the treatment. The main goal is to see if the tubes open up, checked by X-ray before and 3 months after treatment.
Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC